Background Whilst the pharmacological profiles and mechanisms of antidepressants are
varied, there are common reasons why they might help people to stop smoking tobacco …

Gender differences in rates of substance abuse have been consistently observed in the
general population and treatment-seeking samples, with men exhibiting significantly higher …

Níveis de evidência Nível A Dados obtidos a partir de múltiplos estudos randomizados de
bom porte, concordantes e/ou de meta-análise robusta de estudos clínicos randomizados …

Level of evidence Level A Data obtained from multiple concordant large randomized trials
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …

Vale salientar que níveis de evidência classificados como B ou C não podem ser
interpretados como recomendações fracas. Existem muitas recomendações consensuais …

Introduction: There is conflicting evidence for gender differences in smoking cessation, and
there has been little research on gender differences in smoking cessation medication (SCM) …

Introduction Given the rapid increase in e-cigarette use, it is important to understand factors
that may contribute to their initiation and maintenance. Because gender differences in …

Compared to men, women may be at greater risk for smoking-related diseases and have
greater difficulty quitting smoking. Sex differences in medication response could guide …

Although smoking cessation is clearly beneficial, many smokers respond poorly to smoking
cessation efforts with rather disappointing overall success rate of long-term abstinence. The …

ABSTRACT Bupropion hydrochloride ((±)‐2‐tert‐butylamino)‐3′‐chloropropiophenone·
HCl) is a nonselective inhibitor of the dopamine transporter (DAT) and the norepinephrine …